Brief: IRLAB Therapeutics Appoints Richard Godfrey As New CEO
10/06/2022 08:06
June 10 (Reuters) - IRLAB Therapeutics AB IRLABa.ST :
* SAID ON THURSDAY APPOINTS RICHARD GODFREY AS NEW CEO
* CURRENT CEO, NICHOLAS WATERS, IS APPOINTED TO THE ROLE OF
EXECUTIVE VICE PRESIDENT AND HEAD OF RESEARCH & DEVELOPMENT
* BOTH WILL TAKE UP THEIR NEW POSITIONS ON 1 JULY
Source text for Eikon: urn:newsml:reuters.com:*:nMFNYLj17
Further company coverage: IRLABa.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))